A detailed history of Silver Lake Advisory, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Silver Lake Advisory, LLC holds 29,671 shares of BMY stock, worth $1.67 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
29,671
Previous 29,350 1.09%
Holding current value
$1.67 Million
Previous $1.22 Million 26.03%
% of portfolio
0.34%
Previous 0.3%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $12,730 - $16,611
321 Added 1.09%
29,671 $1.54 Million
Q2 2024

Aug 15, 2024

BUY
$40.25 - $52.99 $1.18 Million - $1.56 Million
29,350 New
29,350 $1.22 Million
Q1 2024

Apr 23, 2024

BUY
$47.98 - $54.4 $5,949 - $6,745
124 Added 0.43%
29,006 $1.57 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $45,619 - $54,436
-941 Reduced 3.16%
28,882 $1.48 Million
Q3 2023

Oct 25, 2023

SELL
$57.89 - $64.73 $18,814 - $21,037
-325 Reduced 1.08%
29,823 $1.73 Million
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $77,853 - $86,444
-1,222 Reduced 3.9%
30,148 $1.93 Million
Q1 2023

Apr 25, 2023

BUY
$65.71 - $74.53 $8,870 - $10,061
135 Added 0.43%
31,370 $2.17 Million
Q4 2022

Jan 30, 2023

BUY
$68.48 - $81.09 $4,725 - $5,595
69 Added 0.22%
31,235 $2.25 Million
Q3 2022

Oct 20, 2022

BUY
$0.13 - $76.84 $9 - $5,455
71 Added 0.23%
31,166 $2.22 Million
Q2 2022

Jul 28, 2022

BUY
$72.62 - $79.98 $5,156 - $5,678
71 Added 0.23%
31,095 $2.39 Million
Q1 2022

May 02, 2022

BUY
$61.48 - $73.72 $4,979 - $5,971
81 Added 0.26%
31,024 $2.27 Million
Q4 2021

Jan 13, 2022

BUY
$53.63 - $62.52 $4,290 - $5,001
80 Added 0.26%
30,943 $1.93 Million
Q2 2021

Aug 04, 2021

SELL
$61.91 - $67.42 $54,109 - $58,925
-874 Reduced 2.75%
30,863 $2.14 Million
Q1 2021

Apr 27, 2021

BUY
$59.34 - $66.74 $70,317 - $79,086
1,185 Added 3.88%
31,737 $2 Million
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $1.76 Million - $1.99 Million
30,490 Added 49177.42%
30,552 $1.9 Million
Q4 2020

Feb 03, 2021

SELL
$57.74 - $65.43 $1.76 Million - $1.99 Million
-30,422 Reduced 99.8%
62 $1.9 Million
Q3 2020

Nov 04, 2020

SELL
$57.43 - $63.64 $77,071 - $85,404
-1,342 Reduced 4.22%
30,484 $1.84 Million
Q2 2020

Jul 28, 2020

BUY
$54.82 - $64.09 $8,113 - $9,485
148 Added 0.47%
31,826 $1.87 Million
Q1 2020

Apr 22, 2020

SELL
$46.4 - $67.43 $189,776 - $275,788
-4,090 Reduced 11.43%
31,678 $1.77 Million
Q1 2020

Apr 21, 2020

BUY
$46.4 - $67.43 $161,982 - $235,398
3,491 Added 10.82%
35,768 $1.8 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $5,216 - $6,804
106 Added 0.33%
32,277 $2.07 Million
Q3 2019

Oct 21, 2019

BUY
$42.77 - $50.71 $31,093 - $36,866
727 Added 2.31%
32,171 $1.63 Million
Q2 2019

Aug 01, 2019

SELL
$44.62 - $49.34 $16,866 - $18,650
-378 Reduced 1.19%
31,444 $1.43 Million
Q1 2019

Apr 18, 2019

SELL
$45.12 - $53.8 $67.1 Million - $80 Million
-1,486,405 Reduced 97.9%
31,822 $1.52 Million
Q1 2019

Apr 17, 2019

BUY
$45.12 - $53.8 $67.1 Million - $80 Million
1,486,612 Added 4702.24%
1,518,227 $1.52 Million
Q4 2018

Feb 05, 2019

BUY
$48.76 - $63.23 $14,579 - $18,905
299 Added 0.95%
31,615 $1.64 Million
Q3 2018

Oct 16, 2018

BUY
$55.19 - $62.25 $37,694 - $42,516
683 Added 2.23%
31,316 $1.94 Million
Q3 2018

Oct 15, 2018

SELL
$55.19 - $62.25 $1,931 - $2,178
-35 Reduced 0.11%
30,633 $1.95 Million
Q2 2018

Jul 16, 2018

SELL
$50.53 - $62.98 $14,148 - $17,634
-280 Reduced 0.9%
30,668 $1.71 Million
Q1 2018

Apr 17, 2018

BUY
$59.92 - $68.98 $9,886 - $11,381
165 Added 0.54%
30,948 $1.96 Million
Q4 2017

Jan 31, 2018

BUY
$59.94 - $65.35 $8,991 - $9,802
150 Added 0.49%
30,783 $1.89 Million
Q3 2017

Oct 17, 2017

BUY
$55.23 - $63.74 $1.69 Million - $1.95 Million
30,633
30,633 $1.95 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Silver Lake Advisory, LLC Portfolio

Follow Silver Lake Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Lake Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silver Lake Advisory, LLC with notifications on news.